[HIV: to administer protease inhibitors early].
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D006678:HIV / Q000187:drug effects*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage* / Q000494:pharmacology; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage / Q000494:pharmacology; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000494:pharmacology; D019438:Ritonavir / Q000008:administration & dosage / Q000494:pharmacology; D019258:Saquinavir / Q000008:administration & dosage / Q000494:pharmacology; D013997:Time Factors; D016047:Zalcitabine / Q000008:administration & dosage / Q000494:pharmacology; D015215:Zidovudine / Q000008:administration & dosage / Q000494:pharmacology
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D015215:Zidovudine; D016047:Zalcitabine; D019258:Saquinavir; D019438:Ritonavir